Xtant Medical Holdings Inc. logo

Xtant Medical Holdings Inc. (XMS)

Market Closed
2 Jun, 10:31
XDUS XDUS
0. 3840
-0.004
-1.03%
- Market Cap
90.45 P/E Ratio
- Div Yield
0 Volume
-0.06 Eps
0.388
Previous Close
Add Transaction
Day Range
0.384 0.384
Year Range
0.372 0.79
Want to track XMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

XMS closed yesterday lower at €0.38, a decrease of -1.03% from Monday's close, completing a monthly decrease of -0.52% or €0. Over the past 12 months, XMS stock lost -40.92%.
XMS is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Xtant Medical Holdings Inc. has completed 2 stock splits, with the recent split occurring on Feb 14, 2018.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on AMEX (USD).

XMS Chart

Xtant Medical Q1 Earnings Call Highlights

Xtant Medical Q1 Earnings Call Highlights

Xtant Medical NYSEAMERICAN: XTNT raised its full-year 2026 revenue guidance after announcing a distribution agreement that moves the company into the hemostatic agent market, while first-quarter revenue declined from the prior-year period following divestitures and the loss of certain license revenue.

Marketbeat | 2 weeks ago
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago
Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q4 2025 Earnings Call Transcript

Seekingalpha | 2 months ago

Xtant Medical Holdings Inc. (XMS) FAQ

What is the stock price today?

The current price is €0.3840.

On which exchange is it traded?

Xtant Medical Holdings Inc. is listed on XDUS.

What is its stock symbol?

The ticker symbol is XMS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Xtant Medical Holdings Inc. ever had a stock split?

Xtant Medical Holdings Inc. had 2 splits and the recent split was on Feb 14, 2018.

Xtant Medical Holdings Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Sean E. Browne CEO
XDUS Exchange
US98420P3082 ISIN
US Country
217 Employees
- Last Dividend
28 Jul 2014 Last Split
19 Oct 2015 IPO Date

Overview

Xtant Medical Holdings, Inc. focuses on developing, manufacturing, and marketing a range of regenerative medicine products and medical devices tailored for the needs of orthopedic and neurological surgeons both in the U.S. and internationally. Originating as Bacterin International Holdings, Inc., the company transitioned to its current name in July 2015, embodying a broader scope in regenerative medicine and medical device innovation. Operating from its headquarters in Belgrade, Montana, Xtant Medical Holdings, Inc. leverages cutting-edge science to foster advancements in medical treatments and patient care across various specialties including orthopedics, neurology, and more.

Products and Services

  • OsteoSponge: Offers a natural scaffold facilitating cellular in-growth and exposes bone-forming proteins to optimize healing.
  • OsteoSponge SC: This product is designed to fill bony defects in the subchondral region of joints, aiding in the process of bone regeneration and repair.
  • OsteoSelect DBM Putty: An osteoinductive bone growth material, OsteoSelect DBM Putty supports the restoration of bone defects and voids as a bone graft substitute in various surgical applications.
  • OsteoSelect PLUS DBM Putty: An enhanced version of the DBM Putty, OsteoSelect PLUS is utilized as a bone void filler and bone graft substitute, specifically in the pelvis, extremities, and posterolateral spine.
  • OsteoFactor: Contains a myriad of proteins and peptides supportive of bone formation and remodeling, facilitating effective bone regeneration.
  • OsteoWrap: A regenerative medicine product designed to support bone repair and growth, enhancing the healing ecosystem.
  • OsteoVive Plus: A growth factor enriched cellular bone matrix, intended for effective bone repair and growth stimulation.
  • 3Demin: Represents a family of allografts that maximize the osteoconductivity and osteoinductive potential of human bone, implying high adaptability and functionality in bone regeneration.
  • Sports Allografts: Processed and distributed for crucial ligament repairs, including those required for anterior and posterior cruciate ligament, and meniscal repair.
  • Milled Spinal Allografts: Specialized allografts milled to precise dimensions for cortical bone applications, typically utilized in spinal surgeries.
  • Traditional Allografts: Provided for a range of applications across orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive operations.
  • Certex Spinal Fixation, Spider Cervical Plating, Axle Interspinous Fusion, Silex Sacroiliac Joint Fusion, Xpress Minimally Invasive Pedicle Screw, and Fortex Pedicle Screw Systems: A suite of advanced medical devices offering comprehensive solutions for spinal surgeries, from fixation to fusion technologies.
  • Calix for cervical and thoracolumbar applications, Axle-X Interspinous Fusion System, Irix-C Cervical Integrated Fusion System, and Irix-A Lumbar Integrated Fusion System: These systems provide integrated solutions for spinal fusion surgeries, featuring technologically advanced designs to improve patient outcomes.

Contact Information

Address: 664 Cruiser Lane
Phone: 406 388 0480